Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $111B | +$888M | 145 | 4.17% | Increased |
|
| 2 |
BlackRock
New York
| $101B | +$247M | 157 | 4.32% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $66.2B | -$445M | 118 | 4.94% | Reduced |
|
| 4 |
Wellington Management Group
Boston,
Massachusetts
| $28.1B | +$1.35B | 55 | 6.22% | Increased |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $23.4B | -$606M | 93 | 2.74% | Reduced |
|
| 6 |
Capital World Investors
Los Angeles,
California
| $22.5B | +$282M | 19 | 5.27% | Increased |
|
| 7 |
Capital Research Global Investors
Los Angeles,
California
| $20.6B | -$3.5B | 11 | 6.54% | Reduced |
|
| 8 |
Bank of America
Charlotte,
North Carolina
| $19.7B | -$221M | 150 | 2.98% | Reduced |
|
| 9 |
Geode Capital Management
Boston,
Massachusetts
| $19.6B | +$549M | 154 | 4.74% | Increased |
|
| 10 |
Northern Trust
Chicago,
Illinois
| $18.4B | +$57.9M | 135 | 4.37% | Increased |
|
| 11 |
T. Rowe Price Associates
Baltimore,
Maryland
| $16.7B | -$806M | 72 | 2.35% | Reduced |
|
| 12 |
Bank of New York Mellon
New York
| $16.3B | -$279M | 117 | 4.45% | Reduced |
|
| 13 |
JP Morgan Chase
New York
| $15.5B | -$294M | 126 | 3.03% | Reduced |
|
| 14 |
Capital International Investors
Los Angeles,
California
| $14.9B | +$228M | 21 | 5.94% | Increased |
|
| 15 |
Norges Bank
Oslo,
Norway
| $14.2B | +$142M | 43 | 4.4% | Increased |
|
| 16 |
Primecap Management
Pasadena,
California
| $11.9B | -$237M | 15 | 8.82% | Reduced |
|
| 17 |
Invesco
Atlanta,
Georgia
| $11.4B | +$2.51B | 59 | 2.93% | Increased |
|
| 18 |
Wells Fargo
San Francisco,
California
| $11.1B | -$486M | 145 | 3.18% | Reduced |
|
| 19 |
Dodge & Cox
San Francisco,
California
| $10.5B | -$635M | 11 | 8.5% | Reduced |
|
| 20 |
Morgan Stanley
New York
| $10.5B | +$82.5M | 170 | 2.79% | Increased |
|
| 21 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
| $10.4B | -$21.1M | 7 | 12.9% | Reduced |
|
| 22 |
Nuveen
Charlotte,
North Carolina
| $10B | +$9.49B | 91 | 3.95% | Increased |
|
| 23 |
Goldman Sachs
New York
| $9.34B | -$1B | 112 | 2.69% | Reduced |
|
| 24 |
Franklin Resources
San Mateo,
California
| $9.27B | -$226M | 31 | 4.93% | Reduced |
|
| 25 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $8.94B | +$34.1M | 140 | 5.25% | Increased |
|